BREATH OF INNOVATION

Serial Number 88949498
Registration 6496295
700

Registration Progress

Application Filed
Jun 5, 2020
Under Examination
Approved for Publication
Jul 13, 2021
Published for Opposition
Jul 13, 2021
Registered
Sep 28, 2021

Basic Information

Serial Number
88949498
Registration Number
6496295
Filing Date
June 5, 2020
Registration Date
September 28, 2021
Published for Opposition
July 13, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 28, 2021
Registration
Registered
Classes
005 042 044

Rights Holder

VERONA PHARMA PLC

84
Address
ONE CENTRAL SQUARE
CARDIFF CF101FS
GB

Ownership History

Verona Pharma PLC.

Original Applicant
99
Cardiff GB

Verona Pharma PLC.

Owner at Publication
99
Cardiff GB

Verona Pharma PLC.

Original Registrant
99
Cardiff GB

VERONA PHARMA PLC

New Owner After Registration #1
84
CARDIFF GB

Legal Representation

Attorney
John Mueller
USPTO Deadlines 2 active
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
MAINTENANCE
Section 8 (6-Year) Declaration Due (Based on registration date 2021-09-28)
R.PRA Sep 28, 2027 813 days Critical No
MAINTENANCE
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2021-09-28)
R.PRA Sep 28, 2031 2274 days Critical No
Next deadline: Section 8 (6-Year) Declaration Due (Based on registration date 2021-09-28) on September 28, 2027 (813 days)

Application History

28 events
Date Code Type Description
Apr 2, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 5, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 5, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 5, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 5, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 5, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 5, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 5, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 28, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 13, 2021 PUBO A PUBLISHED FOR OPPOSITION
Jul 13, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 23, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 9, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 9, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 9, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED
Jun 9, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jun 9, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED
Jun 7, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2021 ALIE A ASSIGNED TO LIE
Mar 5, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 9, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 9, 2020 GNRT F NON-FINAL ACTION E-MAILED
Sep 9, 2020 CNRT R NON-FINAL ACTION WRITTEN
Sep 9, 2020 DOCK D ASSIGNED TO EXAMINER
Jun 26, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of respiratory conditions and diseases and, in particular, chronic obstructive pulmonary disease, asthma and COVID-19
Class 042
Scientific research for medical purposes
Class 044
Medical services; provision of medical information and services; information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments

Classification

International Classes
005 042 044